On October 29, 2013, partner Sarah Roller spoke at the American Conference Institute's Second Annual Legal, Regulatory and Compliance Forum on Over the Counter Drugs in New York. Ms. Roller's session, "Define, Distinguish & Differentiate: Best Practice Protocols for Adverse Event Reporting of Non-Prescription Drug Products" provided an overview of compliant protocols for adverse events in the OTC space pursuant to 21 USC §379aa, i.e., Serious Adverse Event Reporting for Nonprescription Drugs. Additionally she outlined some best practices and explained record keeping requirements, internal review protocols and new technologies that may enhance reporting by the consumer.

For more information, please click here.